Home » Topics » BioWorld Science

BioWorld Science
RSS

AbbVie presents key events from fourth quarter 2017

Jan. 31, 2018

First Wave Bio cleared to begin clinical testing of lead product candidate

Jan. 31, 2018

Otsuka awarded grant to advance OPC-167832/delamanid combination for tuberculosis

Jan. 31, 2018

Phase I data presented for JCAR-017 in B-NHL

Jan. 30, 2018

Johnson & Johnson reviews pipeline progress of fourth quarter 2017

Jan. 30, 2018

FDA accepts revefenacin NDA

Jan. 30, 2018

ProMetic Life Sciences finalizes design of phase III study of PBI-4050 in IPF

Jan. 30, 2018

Ibentrus identifies new fusion proteins for cancer

Jan. 30, 2018

Duke University patents APC-containing vaccines for cancer

Jan. 30, 2018

Almac Discovery discloses new Wee1 inhibitors

Jan. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld Asia
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...